Shopping Cart
Remove All
Your shopping cart is currently empty
BT-O2C is a highly selective p300 PROTAC degrader that effectively reduces p300 levels in HAP1 cells. It exhibits significant cytotoxicity in CIC:DUX4 sarcoma (CDS) cell lines, with an IC50 of 152-221 nM, and notably decreases the expression of CDS target genes (ETV1, ETV4, ETV5). BT-O2C is applicable in cancer research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | BT-O2C is a highly selective p300 PROTAC degrader that effectively reduces p300 levels in HAP1 cells. It exhibits significant cytotoxicity in CIC:DUX4 sarcoma (CDS) cell lines, with an IC50 of 152-221 nM, and notably decreases the expression of CDS target genes (ETV1, ETV4, ETV5). BT-O2C is applicable in cancer research. |
| In vitro | BT-O2C, at concentrations ranging from 0.1-10 μM over 24 hours, notably degrades p300 in HAPI cells, while its effect on CBP degradation is minor. In NCC-CDS-X1 (IC 50 = 152 nM) and KITRA (IC 50 = 221 nM) cells, BT-O2C at 0.25-4 μM over 48-72 hours exhibits significant cytotoxicity. Additionally, using BT-O2C at 4 μM for 6 hours significantly reduces the expression of CDS target genes in NCC-CDS-X1 cells. |
| Molecular Weight | 973.94 |
| Formula | C48H48F5N9O8 |
| Cas No. | 3055107-34-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.